5:42

GigaGen Doses 1st Patient in Phase 1 Trial of GIGA-2339, Potential Functional Cure for Chronic HBV

10:01

Keep the Value Coming so that Investment Doesn't Stop — GE Aerospace VP

4:18

Does COVID-19 Make a Better Case for Vaccines?

4:42

Imdusiran for Chronic Hepatitis B Achieves Functional Cure in 50% of Patients

7:04

What Should Be Achieved in Phase 3 COVID-19 Vaccine Trials?

13:01

Exploring The Challenges and Insights in Long COVID Treatment and Management

4:46

Insights on Universal Hepatitis B Screening and Treatment Guidelines

33:54

What If You Only Ate Dinner For 30 Days?